Dexmedetomidine sedation experience in hybrid cardiac operations. Article

K.A. Gruzdev, A.A. Margolina, E.A. Tabak’yan, M.G. Lepilin

National medical research centre of cardiology, Moscow, Russia

For correspondence: Kirill A. Gruzdev — M. D., specialist in anesthesiology and intensive care medicine, department of anesthesiology and intensive care medicine National medical research centre of cardiology, Moscow; e-mail:

For citation: Gruzdev KA, Margolina AA, Tabak’yan EA, Lepilin MG. Dexmedetomidine sedation experience in hybrid cardiac operations. Article. Annals of Critical Care. 2019;3:69–76.

DOI: 10.21320/1818-474X-2019-3-69-76


Background. Dexmedetomidine sedation can appear effective anesthesiological management in hybrid cardiac operations.

Objectives. To examine the safety use of dexmedetomidine sedation in hybrid cardiac operations.

Material and Methods. This study includes 132 patients, who underwent hybrid cardiac operations. Patients were randomized into dexmedetomidine (DEX) and general anesthesia (GA) use groups. We evaluated hemodynamics, gas exchange measurements, postoperative complications as primary outcomes of the study.

Results. In DEX group greater hemodynamics stability occured, which reflected in higher systolic (p < 0,0001) and mean arterial pressure (p = 0,019) compared to GA. Significantly lower usage of cathecholamines was defined in DEX versus GA (p = 0,033). The depth of sedation in DEX seemed to be adequate in assessing with RASS and Ramsay score. In DEX we observed highest value of carbon dioxide in arterial blood gas versus GA (47.0 vs 39.0, respectively), with no significant difference in oxygen concentration. Frequency of COPD was significantly higher in DEX group. Higher incidence of postoperative delirium (p = 0,041) was noted in GA (15 %) versus DEX (3,5 %). There was no significant difference in frequency of AKI, renal replacement therapy, stroke, respiratory complications in observed groups. In DEX group GFR values appeared much better than in GA group (p = 0,02).

Conclusions. In hybrid cardiac operations sedation with dexmedetomidine provides hemodynamics stability. Dexmedetomidine set up good anesthesia conditions with adequate gas exchange parameters, that is usefull in patients with COLD. Applying dexmedetomidine, the frequency of postoperative delirium may be reduced. Dexmedetomidine can improve glomerular filtration rate values.

Keywords: dexmedetomidine, sedation, transcatheter aortic valve implantation, delirium.

Received: 28.03.2019

Accepted: 03.09.2019


  1. Имаев Т.Э., Комлев А.Е., Акчурин Р.С. Транскатетерная имплантация аортального клапана. Состояние проблемы, перспективы в России. Рациональная фармакотерапия в кардиологии. 2015; 11(1): 53–59.[Imaev T.E., Komlev A.E., Akchurin R.S. Transcatheter aortic valve implantation. State of the problem, perspectives in Russia. Ratsional`naya terapiya v kardiologii. 2015; 11(1): 53–59. (In Russ)]
  2. Акчурин Р., Имаев Т., Лепилин П. и др. Опыт эндоваскулярного протезирования аневризм брюшного отдела аорты. Диагностическая и интервенционная радиология. 2016; 10(1): 35–41. [Akchurin R.S., Imaev T.E., Lepilin P.M. Endovascular repair of abdominal aortic aneurysms. Diagnosticheskaya i interventsionnaya radiologiya. 2016; 10(1): 35–41.(In Russ)]
  3. Bingol Tanriverdi T., Koceroglu I., Devrim S. Comparison of sedation with dexmedetomidine vs propofol during hysteroscopic surgery: Single‐centre randomized controlled trial. J. Clin. Pharm. Ther. 2019; 44: 312–317. DOI: 10.1111/jcpt.12793
  4. Kim K.H. Safe Sedation and Hypnosis using Dexmedetomidine for Minimally Invasive Spine Surgery in a Prone Position. Korean. J. Pain. 2014; 27(4): 313–320. DOI: 10.3344/kjp.2014.27.4.313
  5. Hyman M.C., Vemulapalli S., Szeto W.Y., et al. Conscious sedation versus general anesthesia for transcatheter aortic valve replacement. Insights from the National Cardiovascular Data Registry Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry Circulation. 2017; 136: 2132–2140. DOI: 10.1161/circulationaha.116.026656
  6. Park H.S., Kim K.M., Joung K.W., et al. Monitored anesthesia care with dexmedetomidine in transfemoral percutaneous transcatheter aortic valve implantation: two cases report. Korean. J. Anesthesiol. 2014; 66(4): 317–321. DOI: 10.4097/kjae.2014.66.4.317
  7. Barends C.R., Absalom A., van Minnen B., et al. Dexmedetomidine versus Midazolam in Procedural Sedation. A Systematic Review of Efficacy and Safety. PLoS ONE. 2017; 12(1): e0169525. DOI: 10.1371/journal.pone.0169525
  8. Husser O., Fujita B., Hengstenberg C., et al. Conscious Sedation Versus General Anesthesia in Transcatheter Aortic Valve Replacement: The German Aortic Valve Registry. JACC Cardiovasc. Interv. 2018; 11: 567–578. DOI: 10.1055/s-0038-1627862
  9. Mayr N.P., Wiesner G., van der Starre P., et al. Dexmedetomidine versus propofol-opioid for sedation in transcatheter aortic valve implantation patients: a retrospective analysis of periprocedural gas exchange and hemodynamic support. Can. J. Anaesth. 2018; 65(6): 647–657. DOI: 10.1007/s12630-018-1092-4
  10. Khalil M., Al-Agaty A., Asaad O., et al. A comparative study between propofol and dexmedetomidine as sedative agents during performing transcatheter aortic valve implantation. J. Clin. Anesth. 2016; 32: 242–247. DOI: 10.1016/j.jclinane.2016.03.014
  11. Gong Z., Ma L., Zhong Y.L., et al. Myocardial protective effects of dexmedetomidine in patients undergoing cardiac surgery: A meta-analysis and systematic review. Exp. Ther. Med. 2017; 13(5): 2355–2361. DOI: 10.3892/etm.2017.4227
  12. Choudhury M. Dexmedetomidine: The Anesthetic as an Antiarrythmic. Cardiol. Pharmacol. 2015; 4: 3. DOI: 10.4172/2329–6607.1000153
  13. Wang G., Niu J., Li Z., et al. The efficacy and safety of dexmedetomidine in cardiac surgery patients: A systematic review and meta-analysis. PLoS ONE. 2018, 13(9): e0202620. DOI: 10.1371/journal.pone.0202620
  14. Sato K., Jones P.M. Sedation versus general anesthesia for transcatheter aortic valve replacement. J. Thorac. Dis. 2018;10(Suppl 30): S3588–S3594. DOI: 10.21037/jtd.2018.08.89
  15. Maas E.H., Pieters B.M., Van de Velde M., et al. General or Local Anesthesia for TAVI? A Systematic Review of the Literature and Meta-Analysis. Curr. Pharm. Des. 2016; 22(13): 1868–1878. DOI: 10.2174/1381612822666151208121825
  16. Miles L.F., Joshi K.R., Ogilvie E.H., et al. General anaesthesia vs. conscious sedation for transfemoral aortic valve implantation: a single UK centre before‐and‐after study. Anaesthesia. 2016; 71: 892–900. DOI: 10.1111/anae.13522
  17. Томащук Д.И., Мартынов Д.В., Женило В.М. Дексмедетомидин и пропофол для седации при каротидной эндартерэктомии в условиях регионарной анестезии: что лучше для пациента? (Исследование удовлетворенности пациентов). Вестник интенсивной терапии. 2017; 4: 36–41. [Tomashchyk D.I., Martynov D.V., Zhenilo V.M. Dexmedetomidine and propofol for sedation in carotid endartherectomy with regional anesthesia: what is better for patient? (Patient satisfaction survey). Vestnik intensivnoi terapii. 2017; 4: 36–41. (In Russ)]
  18. Дексдор®. Дексмедетомидин. Монография по препарату. Орион Фарма. 2015. [Dexdor®. Dexmedetomidine. Monography on the drug. Orion Pharma. 2015.]
  19. Козлов И.А., Кричевский Л.А. Дексмедетомидин для седации кардиохирургических больных. Патология кровообращения и кардиохирургия. 2014; 3: 67–75. [Kozlov I.A., Krichevskii L.A. Dexmedetomidine for sedation in cardiosurgery patient. Patologiya krovoobrashcheniya i kardiohirurgiya. 2014; 3: 67–75. (In Russ)]
  20. Улиткина О.Н., Гребенчиков О.А., Скрипкин Ю.В. и др. Органопротекторные свойства дексмедетомидина. Вестник анестезиологии и реаниматологии. 2018; 15(2): 55–61. DOI: 10.21292/2078-5658-2018-15-2-55-61. [Ulitkina O.N., Grebenchikov O.A., Skripkin Yu.V., et al. Organoprotective properties of dexmedetomidine. Vestnik anesteziologii i reanimatologii. 2018; 15(2): 55–61. DOI: 10.21292/2078-5658-2018-15-2-55-61 (In Russ)]
  21. Wu M., Liang Y., Dai Z. Perioperative dexmedetomidine reduces delirium after cardiac surgery: A meta-analysis of randomized controlled trials. Journal of Clinical Anesthesia. 2018; 50: 33–42. DOI: 10.1016/j.jclinane.2018.06.045.
  22. Xuejiang D., Jianshe Y., Weidong M. The effect of dexmedetomidine on the perioperative hemodynamics and postoperative cognitive function of elderly patients with hypertension. Study protocol for a randomized controlled trial. Medicine (Baltimore). 2018; 97(43): e12851. DOI: 10.1097/md.0000000000012851
  23. Peng K., Ji F.H., Liu H. Effects of Perioperative Dexmedetomidine on Postoperative Mortality and Morbidity: A Systematic Review and Meta-analysis. Clin. Ther. 2018;7: pii: S0149–2918(18)30549–6. DOI: 10.1016/j.clinthera.2018.10.022
  24. Silva-Jr. J.M., Katayama H.T., Nogueira F.A.M., et al. Comparison of dexmedetomidine and benzodiazepine for intraoperative sedation in elderly patients: a randomized clinical trial. Reg. Anesth. Pain. Med. 2019; 44(3): 319–324. DOI: 10.1136/rapm-2018-100120
  25. Теплякова А.Н. Сравнительная оценка методов интраоперационной седации в аспекте минимизации когнитивной дисфункции у геронтологических больных при эндопротезировании суставов нижней конечности под регионарной анестезией. Автореф. дис. … канд. мед. наук. М., 2016. [Teplyakova A.N. Сomparative assessment of intraoperative sedation methods in aspect of postoperative cognitive dysfunction minimization in geroтещдщпшсфд patients undergoing endoarthroplasty of the lower limbs with regional anesthesia. [dissertation] Moscow; 2016.]
  26. Liu Y., Sheng B., Wang S., et al. Dexmedetomidine prevents acute kidney injury after adult cardiac surgery: a meta-analysis of randomized controlled trials. BMC Anesthesiol. 2018; 18(1): 7. DOI: 10.1186/s12871-018-0472-1
  27. Kim W.H., Hur M., Park S.K., et al. Pharmacological interventions for protecting renal function after cardiac surgery: a Bayesian network meta-analysis of comparative effectiveness. Anaesthesia. 2018; 73(8): 1019–1031. DOI: 10.1111/anae.14227

Treatment of delirium in early postoperative cardiosurgical patients. Article

V.E. Rubinchik, I.Yu. Kasherininov, A.E. Bautin

Almazov National Medical Research Centre, St. Petersburg, Russia

For correspondence: Vadim E. Rubinchik — M. D., associate professor, the chief of the ICU#2 of Almazov National Medical Research Centre, St. Petersburg; e-mail:

For citation: Rubinchik VE, Kasherininov IYu, Bautin AE. Treatment of delirium in early postoperative cardiosurgical patients. Article. Annals of Critical Care. 2019;3:77–83.

DOI: 10.21320/1818-474X-2019-3-77-83


Background. Postoperative delirium is highly relevant in elderly patients who undergo cardiosurgical interventions with cardiopulmonary bypass (CPB), long stay in intensive care unit (ICU), suffering from widespread atherosclerosis and having a wide range of comorbidities.

In the world literature there is a lot of data on the successful use of dexmedetomidine for sedation, prevention and relief of delirium, including patients after open-heart interventions. Comparative evaluation of dexmedetomidine and neuroleptic sedation with “traditional” for Russian Federation management of cardiosurgical patients suffering from postoperative delirium seems to be a relevant clinical and research task.

Objectives. Comparative evaluation of the effectiveness of drug sedation with dexmedetomidine and propofol in cardiosurgical patients with postoperative delirium.

Material and Methods. An open prospective cohort study took place in 2017–2019 and included 42 patients who underwent open-heart intervention with CPB and had delirium in the postoperative period.

Exclusion criteria: severe brachiocephal artery atherosclerosis, acute period or consequences of stroke, signs of acute respiratory failure associated with the pathology of the respiratory system, severe cardiovascular failure, age over 80 years.

Detection and treatment of delirium were performed by an intensivist together with a psychiatrist. Haloperidol was used as the main antipsychotic. Depending on the drug used for medical sedation, the patients were divided into 2 groups: 22 patients underwent medical sedation with propofol, 20 with dexmedetomidine in the form of an extended infusion. According to the results of the study, the length of patients’ stay in the ICU and hospital, the need for vasopressor therapy, mechnical ventilation (MV), and the duration of delirium were analyzed.

Results. In patients of the dexmedetomidine group, compared with the propofol group, the following was observed: less need for vasopressors and the duration of their use, less frequent use of MV (27.2 % versus 10.0 % of cases, p < 0.05), shorter stay in ICU (4.4 ± 1.8 vs 7.2 ± 2.3 days, p < 0.05), and finally, more rapid relief of the delirium itself (34.7 ± 6.8 vs 52.6 ± 8.9 hours, p < 0.05). There was no statistically significant difference between the groups for the length of hospital stay.

Conclusions. In the early postoperative period of open-heart interventions, medical sedation using dexmedetomidine as a component of the delirium therapy seems to be preferable to propofol sedation. Using of dexmedetomidine during study was associated with more rapid relief of the delirium, more favorable hemodynamic profile, less need for MV and duration of MV, as well as shorter duration of stay in the ICU, compared with the use of propofol sedation, which allows us to recommend routine use of dexmedetomidine in the cardiosurgical ICU.

Keywords: cardiosurgery, postoperative period, delirium, sedation, dexmedetomidine.

Received: 26.03.2019

Accepted: 03.09.2019


  1. McKhann G.M., Grega M.A., Borowicz L.M.Jr., et al. Stroke and encephalopathy after cardiac surgery: an update. Stroke. 2006; 37: 562–571. DOI: 10.1161/01.STR.0000199032.78782.6c
  2. Newman M.F., Grocott H.P., Mathew J.P., et al. Report of the substudy assessing the impact of neurocognitive function on quality of life 5 years after cardiac surgery. Stroke. 2001; 32: 2874–2881.
  3. Selnes O.A., Goldsborough M.A., Borowicz L.M.Jr., et al. Determinants of cognitive change after coronary artery bypass surgery: a multifactorial problem. Ann. Thorac. Surg. 1999; 67: 1669–1676.
  4. Maagaard M., Barbateskovic M., Perner A., et al. Dexmedetomidine for the prevention of delirium in critically ill patients — a protocol for a systematic review. Acta Anaesthesiol. Scand. 2019; 63(4): 540–548. DOI: 10.1111/aas.13313
  5. Collet M.O., Caballero J., Sonneville R., et al. Prevalence and risk factors related to haloperidol use for delirium in adult intensive care patients: the multinational AID-ICU inception cohort study. Intensive Care Med. 2018; 44(7): 1081–1089. DOI: 10.1007/s00134-018-5204-y
  6. Allen J., Alexander E. Prevention, recognition, and management of delirium in the intensive care unit. AACN Adv. Crit. Care. 2012; 23(1): 5–11; quiz 2–3. DOI: 10.1097/NCI.0b013e31822c3633
  7. Zaal I.J., Slooter A.J. Delirium in critically ill patients: epidemiology, pathophysiology, diagnosis and management. Drugs. 2012; 72(11): 1457–1471. DOI: 10.2165/11635520-000000000-00000
  8. Kalabalik J., Brunetti L., El-Srougy R. Intensive care unit delirium: a review of the literature. J. Pharm. Pract. 2014; 27(2): 195–207. DOI: 10.1177/ 0897190013513804
  9. Jackson P., Khan A. Delirium in critically ill patients. Crit. Care Clin. 2015; 31(3): 589–603. DOI: 10.1016/j.ccc.2015.03.011
  10. Pandharipande P., Cotton B.A., Shintani A., et al. Prevalence and risk factors for development of delirium in surgical and trauma intensive care unit patients. J. Trauma. 2008; 65(1): 34–41. DOI: 10.1097/TA.0b013e31814b2c4d
  11. Mantz J., Josserand J., Hamada S. Dexmedetomidine: new insights. Eur. J. Anaesthesiol. 2011; 28(1): 3–6. DOI: 10.1097/EJA.0b013e32833e266d
  12. Gerlach A.T., Dasta J.F. Dexmedetomidine: an updated review. Ann. Pharmacother. 2007; 41: 245–254. DOI: 10.1345/aph.1H314
  13. Honey B.L., Benefield R.J., Miller J.L., Johnson P.N. a2-receptor agonists for treatment and prevention of iatrogenic opioid abstinence syndrome in critically ill patients. Ann Pharmacother. 2009; 43: 1506–1511. DOI: 10.1345/aph.1M161
  14. Anger K.E. Dexmedetomidine: a review of its use for the management of pain, agitation, and delirium in the intensive care unit. Curr. Pharm. Des. 2013; 19: 4003–4013. DOI: 10.2174/1381612811319220009
  15. Gerlach A.T., Murphy C.V., Dasta J.F. An updated focused review of dexmedetomidine in adults. Ann. Pharmacother. 2009; 43(12): 2064–2074. DOI: 10.1345/aph.1M310
  16. Keating G.M. Dexmedetomidine: a review of its use for sedation in the intensive care setting. Drugs. 2015; 75(10): 1119–1130. DOI: 10.1007/s40265-015-0419-5
  17. Man Y., Guo Z., Cao J., Mi W. Efficacy of perioperative dexmedetomidine in postoperative neurocognitive function: a meta-analysis. Clin. Exp. Pharmacol. Physiol. 2015; 42(8): 837–842. DOI: 10.1111/1440–1681.12432
  18. Nguyen J., Nacpil N. Effectiveness of dexmedetomidine versus propofol on extubation times, length of stay and mortality rates in adult cardiac surgery patients: a systematic review and meta-analysis. JBI Database System. Rev. Implement. Rep. 2018; 16(5): 1220–1239. DOI: 10.11124/JBISRIR-2017-003488
  19. Peng K., Zhang J., Meng X.W., et al. Optimization of postoperative intravenous patient-controlled analgesia with opioid-dexmedetomidine combinations: an updated meta-analysis with trial sequential analysis of randomized controlled trials. Pain Physician. 2017; 20(7): 569–596.
  20. Zhou C., Zhu Y., Liu Z., Ruan L. Effect of dexmedetomidine on postoperative cognitive dysfunction in elderly patients after general anaesthesia: a meta-analysis. J. Int. Med. Res. 2016; 44(6): 1182–1190. DOI: 10.1177/ 0300060516671623
  21. Liu X., Xie G., Zhang K., et al. Dexmedetomidine vs propofol sedation reduces delirium in patients after cardiac surgery: a meta-analysis with trial sequential analysis of randomized controlled trials. J. Crit. Care. 2017; 38: 190–196. DOI: 10.1016/j.jcrc.2016.10.026
  22. Еременко А.А., Чернова Е.В. Применение дексмедетомидина для внутривенной седации и лечения делирия в раннем послеоперационном периоде у кардиохирургических больных. Анестезиология и реаниматология. 2013; 5: 4–8. [Eremenko A.A., Chernova E.V. Dexomedetomidine use for intravenous sedation and delirium treatment during early postoperative period in cardio-surgical patients. Anesteziologia i reanimatologia. 2013; 5: 4–8. (In Russ)]
  23. Еременко А.А., Чернова Е.В. Лечение делирия в раннем послеоперационном периоде у кардиохирургических пациентов. Анестезиология и реаниматология. 2014; 3: 30–34. [Eremenko A.A., Chernova E.V. Treatment of delirium in cardio-surgical patients in early postoperative period. Anesteziologia i reanimatologia. 2014; 3: 30–34. (In Russ)]
  24. Еременко А.А., Чернова Е.В. Сравнение дексмедетомидина и пропофола при внутривенной седации в раннем послеоперационном периоде у кардиохирургических пациентов. Анестезиология и реаниматология. 2014; 2: 37–41. [Eremenko A.A., Chernova E.V. Comparison of dexmedetomidine and propofol for short-term sedation in early postoperative period after cardiac surgery. Anesteziologia i reanimatologia. 2014; 2: 37–41. (In Russ)]
  25. Никода В., Грицан А., Еременко А., et al. Эффективность и безопасность применения дексмедетомидина для седации больных при проведении продленной ИВЛ в отделениях реанимации и интенсивной терапии (результаты российского многоуровневого исследования). Анестезиология и реаниматология. 2015; 60(5): 47–53.[Nikoda V.V., Gritsan A.I., Eremenko A.A., et al. The efficacy and safety of dexmedetomidine for sedation of patients during prolonged mechanical ventilation in intensive care units (Russian multicenter study results). Anesteziologia i reanimatologia. 2015; 60(5): 47–53. (In Russ)]
  26. Линев Д.В., Ярошецкий А.И., Проценко Д.Н., Гельфанд Б.Р. Эффективность и безопасность дексмедетомидина, галоперидола и диазепама в лечении делирия: сравнительное исследование. Анестезиология и реаниматология. 2017; 62(6): 442–448. DOI: 10.18821/0201-7563-2017-62-6-442-448. [Linev D.V., Yaroshetskiy A.I., Protsenko D.N., Gel’fand B.R. The efficacy and the safety of dexmedetomidine, haloperidol and diazepam for treatment of delirium: a comparative study. Anesteziologiya i reanimatologiya (Russian Journal of Anaesthesiology and Reanimatology). 2017; 62(6): 442–448. (In Russ)]

Evaluation of brain bioelectrical activity during xenon-oxygen mixture inhalation

V.I. Potievskaya1, F.M. Shvetskiy2, M.B. Potievskiy3

FSBI “National Medical Research Radiological Center” of the Ministry of Health of the Russian Federation, Moscow

SBIH “Hospital for war veterans №2”, Moscow

FSBEI HE “Lomonosov Moscow State University”, Moscow

For correspondence: Vera I. Potievskaya, Ph.D., M.D., chief researcher «National Medical Research Radiology Center», Russian Federation Ministry of Healthcare; e-mail:

For citation: Potievskaya VI, Shvetskiy FM, Potievskiy MB. Evaluation of brain bioelectrical activity during xenon-oxygen mixture inhalation. Alexander Saltanov Intensive Care Herald. 2019;1:94–9.

DOI: 10.21320/1818-474X-2019-1-94-99


Xenon is an inert gas used like inhalational anesthetic during different surgeries, including high-risk operations and for pain treatment caused by different factors. If concentration of the gas is less than 50 %, or the duration of the procedure is very short, no consciousness depression occurs. 20 healthy persons from 22 to 30 years old were undergone xenon/oxygen inhalation with concentration 70/30 % respectively for 3 minutes. Electroencephalography (EEG) was recorded before, during and 30 minutes later the procedure. For the data processing spectral analysis was used. Statistical analysis was performed by Wilcoxon and Page tests. As a result, significant increase in slow wave activity and reduction in alpha-rhythm activity were observed during and after the procedure as well as repartition of activity zones in brain similar to physiological sleep. This fact may be used in conduction of treatment and diagnostics procedures.

Keywords: xenon, inhalational anesthetics, mask inhalations of xenon-oxygen mixture, electroencephalography, sedation

Received: 07.10.2018

Accepted: 01.03.2019


  1. Буров Н.Е., Потапов В.Н. Ксенон в медицине: очерки по истории и применению медицинского ксенона. М.: Пульс, 2012.
  2. [Burov N.E., Potapov V.N. Ksenon v medicine: ocherki po istorii i primeneniyu medicinskogo ksenona (Xenon in medicine: history and using). Moscow: Pulʼs Publ., 2012.  (In Russ)]
  3. Lu Tian Liu, Yan Xu, Pei Tang B. Mechanistic Insights into Xenon Inhibition of NMDA Receptors from MD Simulations. J Phys Chem. 2010; 114(27): 9010–9016.
  4. Petrenko A.B., Yamakura T., Sakimura K., Baba H. Defining the role of NMDA receptors in anesthesia: are we there yet? Eur. J. Pharmacol. 2014; 15(1): 723: 29–37.
  5. Рылова А.В., Лубнин А.Ю. Динамика внутричерепного давления во время ксеноновой анестезии у нейрохирургических больных без внутричерепной гипертензии. Анестезиология и реаниматология. 2011; 4: 13–17.
  6. [Rylova A.V., Lubnin A.Yu. Dinamika vnutricherepnogo davleniya vo vremya ksenonovoj anestezii u nejrohirurgicheskih bolʼnyh bez vnutricherepnoj gipertenzii. Anesteziologiya i reanimatologiya (Intracranial pressure changes during xenon anesthesia in neurosurgical patients without intracranial hypertention). Anesteziologiya i Reanimatologiya. 2011; 4: 13–17. (In Russ)]
  7. Козлов И.А. Ксенон при кардиохирургических операциях. Комплексный анализ. Вестник интенсивной терапии. 2007; 3: 45–53.
  8. [Kozlov I.A. Xenon in heart surgeries. Complex analysis. Vestnik intensivnoj terapii. 2007; 3: 45–53. (In Russ)]
  9. Шебзухова Е.Х., Потиевская В.И, Молчанов И.В. Лечебный наркоз ксеноном при остром коронарном синдроме. Вестник интенсивной терапии. 2014; 5: 95–98.
  10.  [Shebzuhova E.H., Potievskaya V.I., Molchanov I.V. Xenon treatment in patients with acute coronary syndrome. Vestnik intensivnoj terapii. 2014; 5: 95–98. (In Russ)]
  11. Буров Н.Е., Молчанов И.В., Николаев Л.Л. Ксенон в медицине: прошлое, настоящее и будущее. Клиническая практика. 2011; 2: 4–11.
  12. [Burov N.E., Molchanov I.V., Nikolaev L.L. Xenon in medicine: history, nowadays and future. Klinicheskaya praktika. 2011; 2: 4–11. (In Russ)]
  13. Буров Н.Е., Потапов В.Н., Макеев Г.Н. Ксенон в анестезиологии. Клинико-экспериментальные исследования. М.: Пульс, 2000.
  14. [Burov N.E., Potapov V.N., Makeev G.N. Ksenon v anesteziologii. Kliniko-ehksperementalʼnye issledovaniya (Xenon in anesthesiology. Clinical and experimental studies). Moscow: Pulʼs Publ., 2000. (In Russ)]
  15. Bosl W.J. The emerging role of neurodiagnostic informatics in integrated neurological and mental health care. Neurodiagn. J. 2018; 58(3): 143–153. DOI: 10. 1080/21646821.2018.1508983
  16. Ann S., Prim J.H., Alexander M.L., et al. Identifying and engaging neuronal oscillations by transcranial alternating current stimulation in patients with chronic low back pain: a randomized crossover, double-blind, sham-controlled pilot study. J. Pain. 2018; 27(9): 1526–1559. DOI: 10.1016/jpain2018.09.004
  17. Николаев Л.Л. Варианты низкопоточной анестезии ксеноном. М: Город, 2014.
  18. [Nikolaev L.L. Varianty nizkopotochnoj anestezii ksenonom. (Types of lowflow Xenon anesthesia). Moscow: Gorod Publ., 2014. (In Russ)]
  19. Рылова А.В., Сазонова О.Б., Лубнин А.Ю., Машеров Е.Л. Изменения биоэлектрической активности мозга в условиях ксеноновой анестезии у нейрохирургических больных. Анестезиология и реаниматология. 2010; 2: 31–33.
  20. [Rylova A.V., Sazonova O.B., Lubnin A.Yu., Masherov Ye.L. Izmeneniya bioehlektricheskoj aktivnosti mozga v usloviyah ksenonovoj anestezii u nejrohirurgicheskih bolʼnyh (Changes in brain bioelectrical activity during xenon anesthesia in neurosurgical patients). Anesteziologiya i Reanimatologiya. 2010; 2: 31–33. (In Russ)]
  21. Basar E. Brain Function and Oscillations. Integrative Brain Function, Neurophysiology and Cognitive Processes. Berlin: Springer Verlag, 1999; 2: 213–254.
  22. Klimesch W. EEG alpha and theta oscillations reflect cognitive and memory performance: A review and analysis. Brain Research Reviews. 1999; 29: 169–195.